395 related articles for article (PubMed ID: 34596865)
1. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
Sun X; Pan CQ; Xing H
Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
Kang Y; Cai Y
J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
[TBL] [Abstract][Full Text] [Related]
4. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
Li X; Wu S; Du Y; Yang L; Li Y; Hong B
Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
6. The role of gut microbiota in hepatitis B disease progression and treatment.
Chen B; Huang H; Pan CQ
J Viral Hepat; 2022 Feb; 29(2):94-106. PubMed ID: 34415656
[TBL] [Abstract][Full Text] [Related]
7. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection.
Yang R; Xu Y; Dai Z; Lin X; Wang H
J Immunol Res; 2018; 2018():2361963. PubMed ID: 30148173
[TBL] [Abstract][Full Text] [Related]
8. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice.
Zhu Q; Xia P; Zhou X; Li X; Guo W; Zhu B; Zheng X; Wang B; Yang D; Wang J
Front Cell Infect Microbiol; 2019; 9():377. PubMed ID: 31750262
[TBL] [Abstract][Full Text] [Related]
10. Microbiota and viral hepatitis: State of the art of a complex matter.
Milosevic I; Russo E; Vujovic A; Barac A; Stevanovic O; Gitto S; Amedei A
World J Gastroenterol; 2021 Sep; 27(33):5488-5501. PubMed ID: 34588747
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
14. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review.
Ouyang J; Zaongo SD; Zhang X; Qi M; Hu A; Wu H; Chen Y
Front Immunol; 2021; 12():755890. PubMed ID: 35069530
[TBL] [Abstract][Full Text] [Related]
15. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
[TBL] [Abstract][Full Text] [Related]
17. The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.
Sun C; Zhu D; Zhu Q; He Z; Lou Y; Chen D
Front Cell Infect Microbiol; 2024; 14():1337223. PubMed ID: 38404291
[TBL] [Abstract][Full Text] [Related]
18. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure.
Yao X; Yu H; Fan G; Xiang H; Long L; Xu H; Wu Z; Chen M; Xi W; Gao Z; Liu C; Gong W; Yang A; Sun K; Yu R; Liang J; Xie B; Sun S
Front Cell Infect Microbiol; 2021; 11():573923. PubMed ID: 33889550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
